March 12 (Reuters) - EUROFINS SCIENTIFIC SE:
* EUROFINS SCIENTIFIC SUPPORTS SARS-COV-2 ANALYSES NEEDS IN THE U.S.A. AND IN EUROPE WITH MULTIPLE TESTING OPTIONS
* ON CORONAVIRUS: NEXT WEEK DIATHERIX EUROFINS LAB EXPECTS TO BEGIN TESTING FOR SARS-COV-2 AS PART OF ITS NEWLY UPDATED TARGET ENRICHED MULTIPLEX PCR (TEM-PCR) RESPIRATORY VIRAL PANELS
* EUROFINS’ LABORATORIES IN FRANCE, THE BENELUX AND SPAIN ARE GETTING READY TO START TESTING FOR COVID-19 IMMEDIATELY WITH TESTS THEY DEVELOPED AND VALIDATED, AFTER APPROVAL BY PUBLIC HEALTH AUTHORITIES WHICH IS EXPECTED SHORTLY
* ON CORONAVIRUS: ON 13 MARCH 2020, VIRACOR EUROFINS, INFECTIOUS DISEASES TESTING LAB, IS LAUNCHING STAND-ALONE REAL TIME REVERSE TRANSCRIPTASE PCR ASSAY FOR QUALITATIVE DETECTION OF SARS-COV-2 Source text for Eikon: Further company coverage: (Gdansk Newsroom)
Our Standards: The Thomson Reuters Trust Principles.